tiprankstipranks
Advertisement

SCHF - ETF AI Analysis

Compare

Top Page

SCHF

Schwab International Equity ETF (SCHF)

Rating:60Neutral
Price Target:
SCHF (Schwab International Equity ETF) has a solid overall rating, suggesting it offers a reasonably strong mix of quality and stability in its international holdings. High-quality companies like HSBC, Novartis, and AstraZeneca support the fund’s rating through strong financial performance, positive earnings outlooks, and solid balance sheets, while holdings such as Roche and Shell add stability but face valuation or growth challenges that may limit upside. A key risk is that several major positions are large global financial and healthcare firms, so setbacks in these sectors could have an outsized impact on the fund.
Positive Factors
Very Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries such as Japan, the UK, Europe, Canada, and Australia help reduce the impact of problems in any single market.
Strong Contribution from Key Holdings
Several top positions, including ASML, HSBC, Shell, and Commonwealth Bank of Australia, have shown strong or steady performance, supporting the ETF’s recent gains.
Negative Factors
Limited U.S. Focus
Because this is an international fund with only modest U.S. exposure, it may lag when U.S. stocks are leading global markets.
Exposure to Lagging Blue-Chip Stocks
Some major holdings like Nestlé, Roche, and Toyota have shown weaker recent performance, which can drag on overall returns.
Heavy Weight in Financials
A sizable allocation to financial companies means the fund can be more sensitive to changes in interest rates and banking sector stress.

SCHF vs. SPDR S&P 500 ETF (SPY)

SCHF Summary

SCHF is the Schwab International Equity ETF, which follows the FTSE Developed ex US Index. That means it invests in many companies from developed countries outside the United States, such as Japan, the UK, and Europe. It holds well-known names like Nestlé, Toyota, and HSBC, and spreads money across many sectors, including financials, industrials, and health care. Someone might invest in SCHF to diversify beyond U.S. stocks and tap into long-term growth in global markets at a low cost. A key risk is that international stocks can be volatile and can go up or down with global market and currency swings.
How much will it cost me?The Schwab International Equity ETF (SCHF) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because SCHF is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?The Schwab International Equity ETF (SCHF) could benefit from global economic growth, particularly in developed markets outside the U.S., as well as advancements in sectors like technology and healthcare, which are among its top holdings. However, it may face challenges from rising interest rates, currency fluctuations, or geopolitical tensions that could negatively impact international markets and sectors like financials and energy. Regulatory changes in key regions or slower growth in developed economies could also affect its performance.

SCHF Top 10 Holdings

SCHF’s story is all about broad developed-markets exposure, with a noticeable tilt toward European heavyweights. ASML has been the star of the show, rising strongly and giving the fund a tech-powered boost, while HSBC and Royal Bank of Canada add steady fuel from the financial side. On the defensive front, big pharma names like Roche and Novartis have been more mixed, and AstraZeneca is losing a bit of steam. Nestlé has also been lagging, acting as a mild brake on performance. Overall, it’s a globally diversified, non-U.S. mix without any single stock dominating the stage.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
3.46%$2.24B
2.73%$1.77B
ASML Holding NV2.33%$1.51B€575.73B130.86%
76
Outperform
HSBC Holdings1.04%$672.68M£222.25B47.99%
80
Outperform
Novartis AG0.98%$636.43MCHF217.32B22.72%
80
Outperform
Roche Holding AG0.97%$626.36MCHF258.35B22.43%
73
Outperform
Royal Bank Of Canada0.95%$617.05M$276.40B54.53%
75
Outperform
AstraZeneca0.94%$609.83M$279.48B23.45%
80
Outperform
Nestlé SA0.87%$559.98MCHF205.08B-4.04%
71
Outperform
Shell (UK)0.84%$540.94M£179.92B25.30%
73
Outperform

SCHF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
26.82
Positive
100DMA
26.20
Positive
200DMA
24.72
Positive
Market Momentum
MACD
0.17
Positive
RSI
56.70
Neutral
STOCH
54.17
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.38, equal to the 50-day MA of 26.82, and equal to the 200-day MA of 24.72, indicating a bullish trend. The MACD of 0.17 indicates Positive momentum. The RSI at 56.70 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCHF.

SCHF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$64.19B0.03%
60
Neutral
$223.93B0.03%
59
Neutral
$40.06B0.03%
59
Neutral
$29.98B0.04%
66
Neutral
$16.67B0.23%
65
Neutral
$16.24B0.18%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCHF
Schwab International Equity ETF
27.74
6.69
31.78%
VEA
Vanguard FTSE Developed Markets ETF
SPDW
SPDR Portfolio Developed World ex-US ETF
IDEV
iShares Core MSCI International Developed Markets ETF
AVDE
Avantis International Equity ETF
DFAI
Dimensional International Core Equity Market ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement